MarketInOut Stock Screener Log In | Sign Up
 

Moderna Inc

XETRA • Healthcare • Biotechnology • Quote as of 10/15/2026 09:12
Moderna Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeXETRA
Market Capitalization75,839 mln
Float365 mln
Earnings Date11/05/2026

Piotroski F-Score

1 / 9
Very weak

Beneish M-Score

-3.22
Reliable

Relative Strength

98 / 100
Top performer

Debt / Equity

0.19
Very low leverage

Pre-Tax Margin

-139%
Severely loss-making

ROE

-37.92
Deeply negative

Business Description

Moderna is a biotechnology company founded in 2010 and based in Cambridge, Massachusetts, that develops medicines using messenger RNA technology. Its product portfolio spans vaccines for respiratory illnesses, viral infections, and bacterial diseases, as well as treatments for certain cancers and rare genetic conditions. The company works alongside prominent partners including Merck, Vertex Pharmaceuticals, the Bill & Melinda Gates Foundation, and OpenAI to advance its research and bring new treatments to patients around the world.

Key Fundamentals

EPS-7.86
ROE-37.92
ROIC-49.23
ROA-26.73
EBITDA, mln-2,404
EV / EBITDA-27.57
EV / EBIT-25.39
Revenue, mln1,909
EV / Revenue34.70

Quote Details

Last 198.16
Change 2 (1.02%)
Open 199.54
Volume 517
Turnover 102,449
Average Volume 29,643

Financial Ratios

Pre-Tax Profit Margin-139
Current Ratio2.30
Price / Book11.30
Price / Tangible Book11.58
Debt / Equity0.19
Price / Sales33.70

Financial Strength

Altman Z-Score11.9
Piotroski F-Score 1 / 9
Beneish M-Score-3.22
Price to Intrinsic Value4.06
Shiller PE Ratio188

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 13.21% 99 / 100   
1 Month 56.2% 100 / 100   
2 Months 229% 100 / 100   
6 Months 328% 100 / 100   
1 Year 728% 100 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us